MYGN FY 2013 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$454M

FY 2013 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$778M+26.9% YoY

Gross Profit

$669M86.0% margin

Operating Income

$274M35.3% margin

Net Income

$176M22.6% margin

EPS (Diluted)

$2.25

Cash Flow

Operating Cash Flow

$190M

Free Cash Flow

$176M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$824M

Total Liabilities

$105M

Stockholders' Equity

$719M

Cash & Equivalents

$65M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$778M	$613M	+26.9%
Gross Profit	$669M	$534M	+25.4%
Operating Income	$274M	$228M	+20.4%
Net Income	$176M	$147M	+19.8%